GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Series GSE25429
Query DataSets for GSE25429
Status
Public on Nov 17, 2010
Title
Gene expression profiles of primary cultured ovarian cells and ovarian cancer cell lines in the presence and absence of a DNA methyltransferase inhibitor
Organism
Homo sapiens
Experiment type
Expression profiling by array
Summary
This SuperSeries is composed of the SubSeries listed below.
Overall design
Refer to individual Series
Citation(s)
21156726
,
24195060
,
23745176
Submission date
Nov 16, 2010
Last update date
Oct 28, 2019
Contact name
Susan K. Murphy
Organization name
Duke University Medical Center
Department
Obstetrics and Gynecology
Street address
B226 LSRC B Wing, Research Drive, Box 91012
City
Durham
State/province
NC
ZIP/Postal code
27708
Country
USA
Platforms (2)
GPL570
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
GPL3921
[HT_HG-U133A] Affymetrix HT Human Genome U133A Array
Samples (129)
Less...
More...
GSM624145
NO1_Mock
GSM624146
NO2_Mock
GSM624147
BorOC2_Mock
GSM624148
BorOC28_Mock
GSM624149
OC1_Mock
GSM624150
OC5_Mock
GSM624151
OC6_Mock
GSM624152
OC7_Mock
GSM624153
OC10_Mock
GSM624154
OC14_Mock
GSM624155
OC15_Mock
GSM624156
OC16_Mock
GSM624157
OC18_Mock
GSM624158
OC20_Mock
GSM624159
OC22_Mock
GSM624160
OC26_Mock
GSM624161
OC27_Mock
GSM624162
NO1_Aza
GSM624163
NO2_Aza
GSM624164
BorOC2_Aza
GSM624165
BorOC28_Aza
GSM624166
OC1_Aza
GSM624167
OC5_Aza
GSM624168
OC6_Aza
GSM624169
OC7_Aza
GSM624170
OC10_Aza
GSM624171
OC14_Aza
GSM624172
OC15_Aza
GSM624173
OC16_Aza
GSM624174
OC18_Aza
GSM624175
OC20_Aza
GSM624176
OC22_Aza
GSM624177
OC26_Aza
GSM624178
OC27_Aza
GSM624179
41M-cisR-Mock treated
GSM624180
HEY-Mock treated
GSM624181
HEYA8-Mock treated
GSM624182
HEYC2-Mock treated
GSM624183
PEO1-Mock treated
GSM624184
PEO4-Mock treated
GSM624185
MCF7-Mock treated
GSM624186
OVCAR-2-Mock treated
GSM624187
OVCAR-3-Mock treated
GSM624188
OVCAR-5-Mock treated
GSM624189
OVCAR-8-Mock treated
GSM624190
OVCAR-10-Mock treated
GSM624191
SKOV-3-Mock treated
GSM624192
SKOV-4-Mock treated
GSM624193
SKOV-6-Mock treated
GSM624194
SKOV-8-Mock treated
GSM624195
OVCA420-Mock treated
GSM624196
OVCA429-Mock treated
GSM624197
OVCA432-Mock treated
GSM624198
OVCA433-Mock treated
GSM624199
OVARY1847-Mock treated
GSM624200
PA-1-Mock treated
GSM624201
DOV13A-Mock treated
GSM624202
DOV13B-Mock treated
GSM624203
DOV13-Mock treated
GSM624204
CAOV-2-Mock treated
GSM624205
CAOV-3-Mock treated
GSM624206
CH1-Mock treated
GSM624207
CH1-cisR-Mock treated
GSM624208
TOV-112D-Mock treated
GSM624209
Tyk-nu-Mock treated
GSM624210
Tyk-nu-cisR-Mock treated
GSM624211
A2780-Mock treated
GSM624212
A2780-cisR-Mock treated
GSM624213
FUOV1-Mock treated
GSM624214
OV90-Mock treated
GSM624215
ME-180-Mock treated
GSM624216
IGROV1-Mock treated
GSM624217
ME-180A-Mock treated
GSM624218
41M-Mock treated
GSM624219
TOV-21G-Mock treated
GSM624220
ME-180C-Mock treated
GSM624221
MCAS-Mock treated
GSM624222
41M-cisR-Decitabine treated
GSM624223
HEY-Decitabine treated
GSM624224
HEYA8-Decitabine treated, rep1
GSM624225
HEYC2-Decitabine treated
GSM624226
PEO1-Decitabine treated
GSM624227
PEO4-Decitabine treated
GSM624228
MCF7-Decitabine treated
GSM624229
OVCAR-2-Decitabine treated
GSM624230
OVCAR-3-Decitabine treated
GSM624231
OVCAR-5-Decitabine treated
GSM624232
OVCAR-8-Decitabine treated
GSM624233
OVCAR-10-Decitabine treated
GSM624234
SKOV-3-Decitabine treated
GSM624235
SKOV-4-Decitabine treated
GSM624236
SKOV-6-Decitabine treated
GSM624237
SKOV-8-Decitabine treated
GSM624238
OVCA420-Decitabine treated
GSM624239
OVCA429-Decitabine treated
GSM624240
OVCA432-Decitabine treated
GSM624241
OVCA433-Decitabine treated
GSM624242
OVARY1847-Decitabine treated
GSM624243
PA-1-Decitabine treated
GSM624244
DOV13A-Decitabine treated
GSM624245
DOV13B-Decitabine treated
GSM624246
DOV13-Decitabine treated
GSM624247
CAOV-2-Decitabine treated
GSM624248
CAOV-3-Decitabine treated
GSM624249
CH1-Decitabine treated
GSM624250
CH1-cisR-Decitabine treated
GSM624251
TOV-112D-Decitabine treated
GSM624252
Tyk-nu-Decitabine treated
GSM624253
Tyk-nu-cisR-Decitabine treated
GSM624254
A2780-Decitabine treated
GSM624255
A2780-cisR-Decitabine treated
GSM624256
FUOV1-Decitabine treated
GSM624257
OV90-Decitabine treated
GSM624258
ME-180-Decitabine treated
GSM624259
IGROV1-Decitabine treated
GSM624260
ME-180A-Decitabine treated
GSM624261
41M-Decitabine treated
GSM624262
TOV-21G-Decitabine treated
GSM624263
ME-180C-Decitabine treated
GSM624264
MCAS-Decitabine treated
GSM624265
A2780(CD133+)-Mock treated
GSM624266
A2780(CD133+)-Decitabine treated
GSM624267
A2780(CD133-)-Mock treated
GSM624268
A2780(CD133-)-Decitabine treated
GSM624269
PEO1(CD133+)-Mock treated
GSM624270
PEO1(CD133+)-Decitabine treated
GSM624271
PEO1(CD133-)-Mock treated
GSM624272
PEO1(CD133-)-Decitabine treated
GSM624273
HEYA8-Decitabine treated, rep2
This SuperSeries is composed of the following SubSeries:
GSE25427
Gene expression profiles of primary cultured ovarian cells in the presence and absence of a DNA methyltransferase inhibitor
GSE25428
Gene expression profiles of ovarian cancer cell lines in the presence and absence of a DNA methyltransferase inhibitor
Relations
BioProject
PRJNA133783
Download family
Format
SOFT formatted family file(s)
SOFT
MINiML formatted family file(s)
MINiML
Series Matrix File(s)
TXT
Supplementary file
Size
Download
File type/resource
GSE25429_RAW.tar
517.2 Mb
(http)
(custom)
TAR (of CEL)
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|